Here's the live share price of Gujarat Themis Biosyn along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Gujarat Themis Biosyn has gained 65.43% CAGR. Over the past year, the corresponding return has been 30.05%.
Gujarat Themis Biosyn’s current P/E of 91.79x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn | 3.06 | -7.56 | 4.76 | 28.23 | 29.84 | 53.59 | 65.38 |
| Sun Pharmaceutical Industries | -2.77 | -2.22 | 5.35 | 5.90 | -4.32 | 20.87 | 25.87 |
| Divi's Laboratories | 0.94 | 0.52 | 4.65 | -0.09 | 11.43 | 24.68 | 12.30 |
| Torrent Pharmaceuticals | -0.92 | 0.66 | 3.39 | 18.51 | 8.28 | 32.98 | 22.99 |
| Cipla | -0.75 | -1.35 | -4.42 | 1.52 | -0.01 | 11.16 | 14.12 |
| Dr. Reddy's Laboratories | -0.48 | 1.87 | -3.72 | -3.99 | -3.96 | 13.13 | 4.68 |
| Lupin | 0.21 | 4.61 | 3.03 | 9.62 | -2.02 | 42.73 | 17.89 |
| Zydus Lifesciences | -1.72 | -1.86 | -11.95 | -3.87 | -7.37 | 30.66 | 15.08 |
| Mankind Pharma | -1.75 | -3.68 | -19.53 | -7.81 | -25.89 | 14.57 | 8.50 |
| Aurobindo Pharma | 1.87 | -1.37 | 8.73 | 12.25 | -3.14 | 40.57 | 7.53 |
| Alkem Laboratories | -2.12 | -3.86 | -0.41 | 15.37 | 0.26 | 22.46 | 13.89 |
| Abbott India | 0.43 | -5.07 | -7.33 | -9.46 | -3.35 | 10.38 | 12.15 |
| Laurus Labs | 2.61 | 5.47 | 11.77 | 61.24 | 81.84 | 39.00 | 25.75 |
| Glenmark Pharmaceuticals | -0.86 | 6.35 | -6.12 | 19.34 | 27.08 | 67.52 | 31.95 |
| Biocon | 2.55 | -3.26 | 7.38 | 13.74 | 13.17 | 14.66 | -2.52 |
| GlaxoSmithKline Pharmaceuticals | -2.31 | 0.78 | -7.30 | -20.54 | 9.15 | 24.00 | 10.38 |
| Anthem Biosciences | -2.41 | 6.11 | -19.43 | -6.59 | -6.59 | -2.25 | -1.35 |
| Ipca Laboratories | -4.22 | -2.82 | -1.71 | 3.26 | -11.81 | 18.04 | 4.83 |
| Ajanta Pharma | -1.23 | 4.43 | 3.21 | 3.27 | -8.72 | 30.68 | 19.90 |
| J B Chemicals & Pharmaceuticals | -0.87 | 1.79 | 4.08 | 6.76 | -6.72 | 20.11 | 27.64 |
Over the last one year, Gujarat Themis Biosyn has gained 29.84% compared to peers like Sun Pharmaceutical Industries (-4.32%), Divi's Laboratories (11.43%), Torrent Pharmaceuticals (8.28%). From a 5 year perspective, Gujarat Themis Biosyn has outperformed peers relative to Sun Pharmaceutical Industries (25.87%) and Divi's Laboratories (12.30%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 390.84 | 389.99 |
| 10 | 386.25 | 391.23 |
| 20 | 397.85 | 399.06 |
| 50 | 425.56 | 409.24 |
| 100 | 404.18 | 398.75 |
| 200 | 354.19 | 371.49 |
In the latest quarter, Gujarat Themis Biosyn remained same as its previous close in promoter holding, while DII stake unchanged at 1.17%, FII holding rose to 2.95%, and public shareholding moved down to 25.01% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,58,000 | 0.61 | 10.52 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 11, 2025, 12:26 AM IST | Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 11, 2025, 12:03 AM IST | Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Change in Management |
| Nov 10, 2025, 9:49 PM IST | Guj. Themis Bios - Results - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2025 |
| Nov 10, 2025, 8:36 PM IST | Guj. Themis Bios - Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (Listing Obligation |
| Nov 04, 2025, 4:35 AM IST | Guj. Themis Bios - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended |
Gujarat Themis Biosyn Ltd. is a Public Limited Listed company incorporated on 11/12/1981 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1981PLC004878 and registration number is 004878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 150.80 Cr. and Equity Capital is Rs. 10.90 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gujarat Themis Biosyn is ₹406.85 as on Dec 19, 2025.
The Gujarat Themis Biosyn is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Gujarat Themis Biosyn is ₹4,433.25 Cr as on Dec 19, 2025.
Today’s highest and lowest price of Gujarat Themis Biosyn are ₹414.20 and ₹387.50.
The 52-week high/low is the highest and lowest price at which Gujarat Themis Biosyn stock has traded in the past 52-week or nearly a year. The 52-week high of Gujarat Themis Biosyn is ₹479.45 and 52-week low of Gujarat Themis Biosyn is ₹192.35 as on Dec 19, 2025.
The Gujarat Themis Biosyn has shown returns of 3.84% over the past day, -7.41% for the past month, 4.93% over 3 months, 30.05% over 1 year, 53.67% across 3 years, and 65.43% over 5 years.
P/E ratio of and PB ratio of Gujarat Themis Biosyn are 91.79 and 19.84 on Dec 19, 2025. While the company gives a dividend yield of 0.16 per annum.